SK Bioscience Co Ltd (302440)

Seoul
156,000.00
-5,500.00(-3.41%)
  • Volume:
    385,956
  • Bid/Ask:
    155,500.00/156,000.00
  • Day's Range:
    154,000.00 - 159,000.00

302440 Overview

Prev. Close
161,500
Day's Range
154,000 - 159,000
Revenue
324.3B
Open
158,500
52 wk Range
111,500 - 190,000
EPS
527.03
Volume
385,956
Market Cap
11.82T
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
915,256
P/E Ratio
306.44
Beta
-
1-Year Change
-
Shares Outstanding
76,500,000
Next Earnings Date
Jun 02, 2021
What is your sentiment on SK Bioscience Co Ltd?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellBuyStrong Buy
Technical IndicatorsBuyStrong SellStrong SellBuyBuy
SummaryNeutralStrong SellStrong SellBuyStrong Buy

SK Bioscience Co Ltd Company Profile

SK Bioscience Co Ltd Company Profile

Employees
0

SK Bioscience Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biological products. The Company's main products include vaccines such as SKYCellflu and Rotatech. The Company also sells infusion solutions. In addition, the Company engages in technology export business. The Company sells its products in domestic and overseas markets.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.